BioNTech SE (BNTX) NASDAQ
$99.27 (1.36) (-1.35%)
Market Cap: $23.60B
As of 09/11/24 04:00 PM EDT. Market closed.
BioNTech SE (BNTX)
NASDAQ
$99.27
(1.36) (-1.35%)
Market Cap: $23.60B
As of 09/11/24 04:00 PM EDT. Market closed.
Add to Portfolio
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II clinical trial to treat HPV+ head and neck cancers; ... read more
COMPANY PROFILE
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Ugur Sahin M.D.
Full Time Employees
6,133
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Ugur Sahin M.D.
Full Time Employees
6,133
URL
Address
An der Goldgrube 12, Mainz, 55131.
PRICE CHART FOR BIONTECH SE
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$100.99
Previous Close
$100.63
Days Range
$97.34 - $101.66
52 week range
$76.53 - $117.98
Volume
872,843
Avg. Volume (30 days)
706,450
Market Cap
$23.60B
Dividend Yield
-
P/E
(42.06)
Shares Outstanding
237,725,735
Open
$100.99
Previous Close
$100.63
Days Range
$97.34 - $101.66
52 week range
$76.53 - $117.98
Volume
872,843
Avg. Volume (30 days)
706,450
Market Cap
$23.60B
Dividend Yield
-
P/E
(42.06)
Shares Outstanding
237,725,735
FINANCIAL STATEMENTS FOR BIONTECH SE
LOADING...
Open in: 
Open in:
FUNDS WITH A POSITION IN BIONTECH SE
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 1,895,427 | 0.00345% | -0.6% | Other |
| CAPITAL WORLD INVESTORS | 955,979 | 0.01% | 1.36% | Growth At A Reasonable Price |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 594,000 | 0.79% | 4.29% | Other |
| CANDRIAM S.C.A. | 578,998 | 0.28% | 261.19% | Other |
| BALYASNY ASSET MANAGEMENT L.P. | 455,918 | 0.06% | 139.83% | Event Driven |
| BAMCO INC /NY/ | 9,850 | 0.00227% | -96.08% | Growth At A Reasonable Price |
| D. E. SHAW & CO., INC. | 183,800 (Put) | 0.01% | -0.81% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 101,499 | 0.00072% | 9.84% | Other |
| D. E. SHAW & CO., INC. | 68,547 | 0.00515% | 131.06% | Other |
| PLATINUM INVESTMENT MANAGEMENT LTD | 41,815 | 0.16% | Exited | Growth At A Reasonable Price, Value |
| D. E. SHAW & CO., INC. | 22,100 (Call) | 0.00166% | 22.78% | Other |
CHANGE IN SHARES OUTSTANDING FOR BIONTECH SE
STOCK BUYBACKS FOR BIONTECH SE
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 06/30/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
03/31/2024
0%
1Q
12/31/2023
0%
2Q
09/30/2023
-0.85%
3Q
06/30/2023
-1.35%
4Q
03/31/2023
-1.36%
5Q
12/31/2022
-2.18%
6Q
09/30/2022
-2.18%
7Q
06/30/2022
-2.18%
8Q
03/31/2022
-3.68%
9Q
12/31/2021
-2.72%
10Q
09/30/2021
-2.60%
11Q
06/30/2021
-2.22%
12Q
03/31/2021
-1.57%
13Q
12/31/2020
4.83%
14Q
09/30/2020
4.83%
15Q
06/30/2020
4.83%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR BIONTECH SE
LOADING...